Towercrest Capital Management Pfizer Inc Transaction History

Towercrest Capital Management

$630 Million
Q3 2024

A detailed history of Towercrest Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Towercrest Capital Management holds 15,107 shares of PFE stock, worth $403,961. This represents 0.07% of its overall portfolio holdings.

Number of Shares

15,107

Previous 15,107 -0.0%

Holding current value

$403,961

Previous $422,000 3.55%

% of portfolio

0.07%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $2,526 - $2,960	100 Added 0.67%	15,107 $422,000
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $43,728 - $50,213	1,689 Added 12.68%	15,007 $416,000
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $62,241 - $80,845	2,382 Added 21.78%	13,318 $383,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $8,664 - $10,127	270 Added 2.53%	10,936 $362,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $141,771 - $164,025	3,925 Added 58.23%	10,666 $391,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $19,695 - $25,640	-500 Reduced 6.91%	6,741 $275,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1,094 - $1,335	25 Added 0.35%	7,241 $317,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $18,300 - $22,676	400 Added 5.87%	7,216 $374,000
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $2,107 - $3,123	-51 Reduced 0.74%	6,816 $403,000
Q3 2021 Dec 10, 2021	SELL	$39.25 - $50.42 $3,100 - $3,983	-79 Reduced 1.14%	6,867 $295,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $5,961 - $6,752	-166 Reduced 2.33%	6,946 $272,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $27,930 - $31,500	-834 Reduced 10.5%	7,112 $258,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $34,172 - $43,453	1,021 Added 14.74%	7,946 $293,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $8,445 - $9,908	266 Added 3.99%	6,925 $254,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $10,325 - $14,752	-382 Reduced 5.43%	6,659 $217,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $3,884 - $4,408	118 Added 1.7%	7,041 $276,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $15,161 - $17,023	410 Added 6.3%	6,923 $299,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $7,537 - $8,281	201 Added 3.18%	6,513 $276,000
Q4 2018 Feb 15, 2019	BUY	$38.47 - $43.86 $961 - $1,096	25 Added 0.4%	6,312 $276,000
Q3 2018 Nov 19, 2018	BUY	$34.47 - $41.81 $216,712 - $262,859	6,287 New	6,287 $277,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Towercrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Towercrest Capital Management with notifications on news.

Account

Towercrest Capital Management Pfizer Inc Transaction History